Sign up to view this video Join Now Patient Voice, • 9/19/25 How to Accelerate the Adoption of Decentralized Trials for Rare Disease Indications Previous Aligning Trials with Patient-Lived Experiences Next Decentralized by Design: Operationalizing Hybrid Rare Disease Trials You Might Also Like Case Studies in Rare Disease Commercialization: Lessons Learned AI-Driven Patient Identification and Recruitment Beyond Biotech: The Rise of Nontraditional Sponsors in Rare Disease Trials Leveraging Patient Advocacy To Scale Rare Disease Trials Rare Isn’t Small: Incorporating Operational Excellence into Global, Multisite Rare Disease Trials
Sign up to view this video Join Now Patient Voice, • 9/19/25 How to Accelerate the Adoption of Decentralized Trials for Rare Disease Indications Previous Aligning Trials with Patient-Lived Experiences Next Decentralized by Design: Operationalizing Hybrid Rare Disease Trials You Might Also Like Case Studies in Rare Disease Commercialization: Lessons Learned AI-Driven Patient Identification and Recruitment Beyond Biotech: The Rise of Nontraditional Sponsors in Rare Disease Trials Leveraging Patient Advocacy To Scale Rare Disease Trials Rare Isn’t Small: Incorporating Operational Excellence into Global, Multisite Rare Disease Trials
